These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 30566932)
1. Efficacy and Safety of Agents in IgA Nephropathy: An Update Network Meta-Analysis. Yang P; Wang Q; Xie C; Xu G; Wu Q Kidney Blood Press Res; 2018; 43(6):1890-1897. PubMed ID: 30566932 [TBL] [Abstract][Full Text] [Related]
2. Comparative Efficacy and Safety of Therapies in IgA Nephropathy: A Network Meta-analysis of Randomized Controlled Trials. Yang P; Zou H; Xiao B; Xu G Kidney Int Rep; 2018 Jul; 3(4):794-803. PubMed ID: 29989013 [TBL] [Abstract][Full Text] [Related]
3. Comparison of inhibitors of renin-angiotensin-aldosterone system (RAS) and combination therapy of steroids plus RAS inhibitors for patients with advanced immunoglobulin A nephropathy and impaired renal function. Moriyama T; Nakayama K; Ochi A; Amemiya N; Tsuruta Y; Kojima C; Itabashi M; Takei T; Uchida K; Nitta K Clin Exp Nephrol; 2012 Apr; 16(2):231-7. PubMed ID: 22038185 [TBL] [Abstract][Full Text] [Related]
4. Treatment of Idiopathic Membranous Nephropathy for Moderate or Severe Proteinuria: A Systematic Review and Network Meta-Analysis. Chen M; Liu J; Xiong Y; Xu G Int J Clin Pract; 2022; 2022():4996239. PubMed ID: 35685506 [TBL] [Abstract][Full Text] [Related]
5. Dual renin-angiotensin system blockade plus oral methylprednisone for the treatment of proteinuria in IgA nephropathy. Trimarchi H; Muryan A; Young P; Forrester M; Iotti A; Pereyra H; Lombi F; Seminario O; Alonso M; Iotti R Medicina (B Aires); 2007; 67(5):445-50. PubMed ID: 18051227 [TBL] [Abstract][Full Text] [Related]
6. The efficacy and safety of immunosuppressive therapies in the treatment of IgA nephropathy: A network meta-analysis. Tan J; Dong L; Ye D; Tang Y; Hu T; Zhong Z; Tarun P; Xu Y; Qin W Sci Rep; 2020 Apr; 10(1):6062. PubMed ID: 32269271 [TBL] [Abstract][Full Text] [Related]
7. Comparative effectiveness and safety for the treatments despite optimized renin-angiotensin system blockade among IgA nephropathy patients at high-risk of disease progression: A network meta-analysis of randomized controlled trials. Tan Q; Xue H; Ni X; Fan L; Du W Eur J Intern Med; 2023 Aug; 114():66-73. PubMed ID: 37179138 [TBL] [Abstract][Full Text] [Related]
8. Add-On Effect of Angiotensin Receptor Blockade (Candesartan) on Clinical Remission in Active IgA Nephropathy Patients Treated with Steroid Pulse Therapy and Tonsillectomy: a Randomized, Parallel-Group Comparison Trial. Kohagura K; Arima H; Miyasato H; Chang TH; Yamazato M; Kobori H; Nishiyama A; Iseki K; Ohya Y Kidney Blood Press Res; 2018; 43(3):780-792. PubMed ID: 29794482 [TBL] [Abstract][Full Text] [Related]
9. The beneficial effects of renin-angiotensin system inhibitors (RASI) on IgA nephropathy with tubulointerstitial lesions categorized by Oxford classification. Kamiyama T; Moriyama T; Kumon S; Karasawa K; Nitta K Clin Exp Nephrol; 2019 Jun; 23(6):834-840. PubMed ID: 30796546 [TBL] [Abstract][Full Text] [Related]
10. Urinary exosomal mRNAs as biomarkers for predicting the therapeutic effect of renin-angiotensin system inhibitors in IgA nephropathy patients. Zhao B; Wang M; Cong Y; Song A; Lu J; Xie K; Dai H; Gu L Clin Chim Acta; 2024 Jul; 561():119750. PubMed ID: 38885756 [TBL] [Abstract][Full Text] [Related]
11. Potential benefits and related treatment effects of calcineurin inhibitors combined with steroid for IgA nephropathy: a systematic review and meta-analysis. Li Z; Yang Z; Ji M Int Urol Nephrol; 2023 Sep; 55(9):2227-2236. PubMed ID: 36856924 [TBL] [Abstract][Full Text] [Related]
12. Effects of combination therapy with renin-angiotensin system inhibitors and eicosapentaenoic acid on IgA nephropathy. Moriyama T; Iwasaki C; Tanaka K; Ochi A; Shimizu A; Shiohira S; Itabashi M; Takei T; Uchida K; Tsuchiya K; Nitta K Intern Med; 2013; 52(2):193-9. PubMed ID: 23318848 [TBL] [Abstract][Full Text] [Related]
13. Plasma exosomal IRAK1 can be a potential biomarker for predicting the treatment response to renin-angiotensin system inhibitors in patients with IgA nephropathy. Wu J; Wei X; Li J; Gan Y; Zhang R; Han Q; Liang P; Zeng Y; Yang Q Front Immunol; 2022; 13():978315. PubMed ID: 36091017 [TBL] [Abstract][Full Text] [Related]
14. Effects of Hydroxychloroquine on Proteinuria in IgA Nephropathy: A Systematic Review and Meta-Analysis. Zhang J; Lu X; Feng J; Li H; Wang S Biomed Res Int; 2021; 2021():9171715. PubMed ID: 34901280 [TBL] [Abstract][Full Text] [Related]
15. Significance of tonsillectomy combined with steroid pulse therapy for IgA nephropathy with mild proteinuria. Komatsu H; Sato Y; Miyamoto T; Tamura M; Nakata T; Tomo T; Nishino T; Miyazaki M; Fujimoto S Clin Exp Nephrol; 2016 Feb; 20(1):94-102. PubMed ID: 26123429 [TBL] [Abstract][Full Text] [Related]
16. A Network Meta-Analysis to Compare the Efficacy of Steroid and Antiviral Medications for Facial Paralysis from Bell´s Palsy. Fu X; Tang L; Wang C; Li M; Wu H; Li J; Ma Q; Yang W Pain Physician; 2018 Nov; 21(6):559-569. PubMed ID: 30508985 [TBL] [Abstract][Full Text] [Related]
17. Comparison of immunosuppressive therapies for IgA nephropathy after tonsillectomy: three-course versus one-course steroid pulse combined with mizoribine. Kaneko T; Arai M; Ikeda M; Morita M; Watanabe Y; Hirama A; Shimizu A; Tsuruoka S Int Urol Nephrol; 2015 Nov; 47(11):1823-30. PubMed ID: 26433884 [TBL] [Abstract][Full Text] [Related]
18. Severity of arterial and/or arteriolar sclerosis in IgA nephropathy and the effects of renin-angiotensin system inhibitors on its prognosis. Sugiura N; Moriyama T; Miyabe Y; Karasawa K; Nitta K J Pathol Clin Res; 2021 Nov; 7(6):616-623. PubMed ID: 34185389 [TBL] [Abstract][Full Text] [Related]
19. A meta-analysis of effects and safety of Tripterygium wilfordii polyglycoside in the treatment of IgA nephropathy. Wang RX; Liao BQ; Chen W; Zhang YM; Tang XH; Xie FH Eur Rev Med Pharmacol Sci; 2022 Dec; 26(23):8756-8770. PubMed ID: 36524494 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of calcineurin inhibitor treatment for IgA nephropathy: a meta-analysis. Song YH; Cai GY; Xiao YF; Wang YP; Yuan BS; Xia YY; Wang SY; Chen P; Liu SW; Chen XM BMC Nephrol; 2017 Feb; 18(1):61. PubMed ID: 28193247 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]